Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

Immune-related adverse events (irAEs) are side effects of immune checkpoint inhibitor therapy (ICI). While common irAEs have been well characterized, there are more limited data on rare immune related adverse events (RirAEs) due to low incidence. Lack of characterization of these entities has led to...

Description complète

Détails bibliographiques

Auteurs principaux:	Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2023-12-01
Collection:	OncoImmunology
Sujets:	Immune checkpoint inhibitor toxicity immune checkpoint inhibitors immune related adverse events melanoma rare immune related adverse events uncommon immune related adverse events
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/2162402X.2023.2188719
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!